רווח נקי למניה (EPS TTM) PepGen Inc. (PEPG)

The annual net income per share trend for PepGen Inc. (PEPG) on the GURU.Markets chart reflects a value maintained at -1.06. PepGen Inc. is implementing robotic bioscreening to accelerate drug development. The company is developing treatments for neuromuscular pathologies based on the EDO system. Patent protection and strict FDA oversight create significant barriers to entry for new players.

Earnings per share (EPS TTM) determines the actual return on each share of investor capital. A snapshot of the annual EPS TTM visualizes the trend of the accumulated financial result over the last four quarters. The metric is calculated by dividing total profit by the total number of outstanding shares. For PepGen Inc. (PEPG), negative values reflect the clinical research stage. Growth in this indicator would signal a transition from investment income to the commercialization of drugs.